Contineum Therapeutics, Inc. (CTNM)
NASDAQ · Healthcare
Contineum Therapeutics, Inc. Net Income 2023–2024
Contineum Therapeutics, Inc. annual/quarterly net income history and growth rate from 2023 to 2024. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- Contineum Therapeutics, Inc. net income for the quarter ending September 30, 2024 was -10.3 M, a 64.25% increase year-over-year.
- Contineum Therapeutics, Inc. net income for the twelve months ending September 30, 2024 was 16.0 M.
- Contineum Therapeutics, Inc. annual net income for 2024 was -42.3 M, a 285.99% decrease from 2023.
- Contineum Therapeutics, Inc. annual net income for 2023 was 22.7 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Contineum Therapeutics, Inc. Net Income — FAQ
Contineum Therapeutics, Inc. (CTNM) net income over the last 2 years — annual and quarterly figures with year-over-year growth and charts.
What is Contineum Therapeutics, Inc.'s net income?
Contineum Therapeutics, Inc. (CTNM) reported net income of -$42M for fiscal 2024.
Where can I see CTNM's net income history?
The chart and table above show Contineum Therapeutics, Inc.'s net income by year and by quarter, including the growth rate.